TE-8214

N/A

Report date: 2024/04/19 20:00:31

Base Information

Drug NameTE-8214
Drug Alias NameOctreotide(Immunwork )TE-8214
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor agonistsInsulin-like growth factor I inhibitors
TargetsSomatostatin receptorInsulin-like growth factor I
Therapy Area/IndicationsAcromegalyNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunwork Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunwork Inc
Inactive CompaniesN/A
Active IndicationsAcromegalyNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A